Understanding the spectrum of cardiovascular risk in women - A primer for prevention

被引:0
作者
Satish, Priyanka [1 ]
Avenatti, Eleonora [1 ]
Patel, Jaideep [2 ]
Agarwala, Anandita [3 ]
机构
[1] Univ Texas Austin, Ctr Cardiovasc Prevent, Dell Med Sch, Ascens Texas Cardiovasc, Austin, TX USA
[2] Johns Hopkins Univ Hosp, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Dis, Baltimore, MD USA
[3] Baylor Scott & White Hlth Heart Hosp Baylor Plano, Ctr Cardiovasc Dis Prevent, Plano, TX USA
关键词
Gender; Women; Cardiovascular disease; Prevention; ISCHEMIC-HEART-DISEASE; GESTATIONAL DIABETES-MELLITUS; ADVERSE PREGNANCY OUTCOMES; CONSENSUS DECISION PATHWAY; 2013; AMERICAN-COLLEGE; SEX-DIFFERENCES; SCIENTIFIC STATEMENT; CORONARY-HEART; UNITED-STATES; GENDER-DIFFERENCES;
D O I
10.1016/j.pcad.2024.05.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) is the leading cause of death in women worldwide and the lifetime risk of CVD in women is similar to men. However, the pathophysiology of CVD varies between women and men necessitating a sex-specific understanding of cardiovascular (CV) risk. A belief that women have a lower CVD risk than men, and an underrepresentation in clinical research for many years has led to a paucity of evidence in the prevention and management of CVD in women. Many recent efforts have tried to bridge the gap. As a result, we now know that traditional risk factors impact CVD risk differently in women when compared with men. There are also numerous sex-specific and pregnancy related risk factors that modify the risk and can predict the future development of CVD in women. This is important as risk calculators, in general, tend to misclassify risk in young women with nontraditional CVD risk factors. To address this, guidelines have introduced the concept of risk enhancers that can suggest a higher risk. The use of coronary artery calcium score can further accurately delineate risk in these women, leading to an appropriate matching of therapy to underlying risk. This review discusses implementation strategies that are essential to mitigate disparities in CVD outcomes and optimizing CVD risk in women.
引用
收藏
页码:34 / 42
页数:9
相关论文
共 130 条
  • [31] Menopause and hypertension - An age-old debate
    Coylewright, Megan
    Reckelhoff, Jane F.
    Ouyang, Pamela
    [J]. HYPERTENSION, 2008, 51 (04) : 952 - 959
  • [32] Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
    Darby, Sarah C.
    Ewertz, Marianne
    McGale, Paul
    Bennet, Anna M.
    Blom-Goldman, Ulla
    Bronnum, Dorthe
    Correa, Candace
    Cutter, David
    Gagliardi, Giovanna
    Gigante, Bruna
    Jensen, Maj-Britt
    Nisbet, Andrew
    Peto, Richard
    Rahimi, Kazem
    Taylor, Carolyn
    Hall, Per
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) : 987 - 998
  • [33] Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Diseases Among Hispanic/Latino Individuals of Diverse Backgrounds in the United States
    Daviglus, Martha L.
    Talavera, Gregory A.
    Aviles-Santa, M. Larissa
    Allison, Matthew
    Cai, Jianwen
    Criqui, Michael H.
    Gellman, Marc
    Giachello, Aida L.
    Gouskova, Natalia
    Kaplan, Robert C.
    LaVange, Lisa
    Penedo, Frank
    Perreira, Krista
    Pirzada, Amber
    Schneiderman, Neil
    Wassertheil-Smoller, Sylvia
    Sorlie, Paul D.
    Stamler, Jeremiah
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (17): : 1775 - 1784
  • [34] Diabetes, Glycated Hemoglobin, and the Risk of Myocardial Infarction in Women and Men: A Prospective Cohort Study of the UK Biobank
    de Jong, Marit
    Woodward, Mark
    Peters, Sanne A. E.
    [J]. DIABETES CARE, 2020, 43 (09) : 2050 - 2059
  • [35] CORRELATION OF HORMONES WITH LIPID AND LIPOPROTEIN LEVELS DURING NORMAL-PREGNANCY AND POSTPARTUM
    DESOYE, G
    SCHWEDITSCH, MO
    PFEIFFER, KP
    ZECHNER, R
    KOSTNER, GM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (04) : 704 - 712
  • [36] Drewnowski A, 2004, AM J CLIN NUTR, V79, P6
  • [37] Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women
    Dugani, Sagar B.
    Moorthy, M. Vinayaga
    Li, Chunying
    Demler, Olga V.
    Alsheikh-Ali, Alawi A.
    Ridker, Paul M.
    Glynn, Robert J.
    Mora, Samia
    [J]. JAMA CARDIOLOGY, 2021, 6 (04) : 437 - 447
  • [38] Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association
    El Khoudary, Samar R.
    Aggarwal, Brooke
    Beckie, Theresa M.
    Hodis, Howard N.
    Johnson, Amber E.
    Langer, Robert D.
    Limacher, Marian C.
    Manson, JoAnn E.
    Stefanick, Marcia L.
    Allison, Matthew A.
    [J]. CIRCULATION, 2020, 142 (25) : e506 - e532
  • [39] Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023
    ElSayed, Nuha A.
    Aleppo, Grazia
    Aroda, Vanita R.
    Bannuru, Raveendhara R.
    Brown, Florence M.
    Bruemmer, Dennis
    Collins, Billy S.
    Hilliard, Marisa E.
    Isaacs, Diana
    Johnson, Eric L.
    Kahan, Scott
    Khunti, Kamlesh
    Leon, Jose
    Lyons, Sarah K.
    Perry, Mary Lou
    Prahalad, Priya
    Pratley, Richard E.
    Seley, Jane Jeffrie
    Stanton, Robert C.
    Gabbay, Robert A.
    [J]. DIABETES CARE, 2023, 46 : S254 - S266
  • [40] Faden R., 1994, WOMEN HLTH RES ETHIC, V1